{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:05:06Z","timestamp":1761102306071,"version":"3.37.3"},"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Indonesian Endowment Fund for Education"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193293","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T17:44:07Z","timestamp":1525887847000},"page":"e0193293","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-5016","authenticated-orcid":true,"given":"T. I. Armina","family":"Padmasawitri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardus W.","family":"Frederix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bachti","family":"Alisjahbana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke M.","family":"H\u00f6vels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2214-109X(14)70361-4","article-title":"The WHO 2014 Global tuberculosis report\u2014further to go","volume":"3","author":"A Zumla","year":"2015","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccm.2009.08.016","article-title":"Novel and improved technologies for tuberculosis diagnosis: progress and challenges","volume":"30","author":"M Pai","year":"2009","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(13)70256-X","article-title":"Tuberculosis: progress and challenges in product development and delivery","volume":"2","author":"M Pai","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-12-103","article-title":"Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review","volume":"12","author":"SD Lawn","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/resp.12067","article-title":"Challenges to the global control of tuberculosis","volume":"18","author":"C-Y Chiang","year":"2013","journal-title":"Respirology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e110558","DOI":"10.1371\/journal.pone.0110558","article-title":"Modeling of novel diagnostic strategies for active tuberculosis\u2014a systematic review: current practices and recommendations","volume":"9","author":"A Zwerling","year":"2014","journal-title":"PloS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0272989X15579173","article-title":"Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries","volume":"36","author":"CEH Boehler","year":"2016","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"year":"2012","author":"DG Walker","key":"ref8"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123853","article-title":"Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development","volume":"10","author":"B Santatiwongchai","year":"2015","journal-title":"PLoS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e56044","DOI":"10.1371\/journal.pone.0056044","article-title":"How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI","volume":"8","author":"O Oxlade","year":"2013","journal-title":"PloS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jval.2015.11.006","article-title":"Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review","volume":"19","author":"M Koufopoulou","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tube.2016.04.007","article-title":"A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups","volume":"99","author":"P Auguste","year":"2016","journal-title":"Tuberc Edinb Scotl"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jval.2011.08.003","article-title":"Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes","volume":"15","author":"GWJ Frederix","year":"2012","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40273-014-0157-7","article-title":"Modelling technique, structural assumptions, input parameter values: which has the most impact on the results of a cost-effectiveness analysis?","volume":"32","author":"J Mauskopf","year":"2014","journal-title":"PharmacoEconomics"},{"key":"ref15","article-title":"Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models","author":"NA Menzies","year":"2016","journal-title":"Lancet Glob Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"A Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"ref17","first-page":"iii","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Z Philips","year":"2004","journal-title":"Health Technol Assess Winch Engl"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jalz.2013.02.005","article-title":"Diagnosing Alzheimer\u2019s disease: a systematic review of economic evaluations","volume":"10","author":"RLH Handels","year":"2014","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5588\/ijtld.12.0573","article-title":"Data Needs for Evidence-Based Decisions: A TB Modeler\u2019s \u201cWish List.\u201d","volume":"17","author":"DW Dowdy","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4419-6064-1_9","article-title":"Mathematical modelling of the epidemiology of tuberculosis","volume":"673","author":"PJ White","year":"2010","journal-title":"Adv Exp Med Biol"},{"year":"2016","key":"ref21","article-title":"Global Tuberculosis Report"},{"key":"ref22","unstructured":"United States Department of Labor. CPI Inflation Calculator [Internet]. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.bls.gov\/cgi-bin\/cpicalc.pl\" xlink:type=\"simple\">http:\/\/data.bls.gov\/cgi-bin\/cpicalc.pl<\/ext-link>"},{"key":"ref23","unstructured":"Office for National Statistics United Kingdom. Consumer Price Inflation: December 2015, CPI index values (2005 = 100), 1-month and 12-month rates: December 2014 to December 2015 [Internet]. 2016. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ons.gov.uk\/economy\/inflationandpriceindices\/bulletins\/consumerpriceinflation\/december2015\" xlink:type=\"simple\">http:\/\/www.ons.gov.uk\/economy\/inflationandpriceindices\/bulletins\/consumerpriceinflation\/december2015<\/ext-link>"},{"key":"ref24","unstructured":"Office for National Statistics United Kingdom. Consumer Price Indices, December 2011,CPI Indices (2005 = 100), 1-month change and 12-month change: December 2010 to December 2011 [Internet]. 2012. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/webarchive.nationalarchives.gov.uk\/20160105160709\/http:\/\/www.ons.gov.uk\/ons\/dcp171778_250279.pdf\" xlink:type=\"simple\">http:\/\/webarchive.nationalarchives.gov.uk\/20160105160709\/http:\/\/www.ons.gov.uk\/ons\/dcp171778_250279.pdf<\/ext-link>"},{"key":"ref25","unstructured":"National Institute of Statistics and Economic Studies. Consumer Price Index\u2014Base 2015\u2014All households\u2014France\u2014All items [Internet]. 2016. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.insee.fr\/en\/bases-de-donnees\/bsweb\/serie.asp?idbank=001759970\" xlink:type=\"simple\">http:\/\/www.insee.fr\/en\/bases-de-donnees\/bsweb\/serie.asp?idbank=001759970<\/ext-link>"},{"key":"ref26","unstructured":"Official Statistics of Finland (OSF). Consumer Price Index 2000 = 100, December 2015, Appendix table 5 [Internet]. 2016. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stat.fi\/til\/khi\/2015\/12\/khi_2015_12_2016-01-14_tau_005_en.html\" xlink:type=\"simple\">http:\/\/www.stat.fi\/til\/khi\/2015\/12\/khi_2015_12_2016-01-14_tau_005_en.html<\/ext-link>"},{"key":"ref27","article-title":"National Accounts: PPPs and Exchange Rates"},{"article-title":"Making choices in health: WHO guide to cost-effectiveness analysis","year":"2003","author":"T Tan-Torres Edejer","key":"ref28"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0b013e318246538f","article-title":"Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy","volume":"60","author":"TO Abimbola","year":"2012","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"ref30","first-page":"571","article-title":"Added value of bleach sedimentation microscopy for diagnosis of tuberculosis: a cost-effectiveness study","volume":"14","author":"M Bonnet","year":"2010","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref31","first-page":"1024","article-title":"Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting","volume":"14","author":"VN Chihota","year":"2010","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.5588\/ijtld.13.0095","article-title":"Cost-effectiveness of Xpert\u00ae MTB\/RIF for diagnosing pulmonary tuberculosis in the United States","volume":"17","author":"HW Choi","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1128\/JCM.41.3.948-953.2003","article-title":"Cost-Effectiveness Analysis of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test as Used Routinely on Smear-Positive Respiratory Specimens","volume":"41","author":"DW Dowdy","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e4057","DOI":"10.1371\/journal.pone.0004057","article-title":"Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults","volume":"3","author":"DW Dowdy","year":"2008","journal-title":"PloS One"},{"key":"ref35","first-page":"1021","article-title":"\u2019Brien MA, Bishai D. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis","volume":"12","author":"O Dowdy DW","year":"2008","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1001074","DOI":"10.1371\/journal.pmed.1001074","article-title":"Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis","volume":"8","author":"DW Dowdy","year":"2011","journal-title":"PLoS Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JCM.01682-08","article-title":"Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis","volume":"46","author":"RL Guerra","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.5588\/ijtld.13.0073","article-title":"Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil","volume":"17","author":"RL Guerra","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.rmed.2011.10.005","article-title":"The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis","volume":"106","author":"R Hughes","year":"2012","journal-title":"Respir Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5588\/ijtld.14.0203","article-title":"Cost-utility analysis of LED fluorescence microscopy in the diagnosis of pulmonary tuberculosis in Indian settings","volume":"19","author":"V Kelly","year":"2015","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/S2214-109X(14)70291-8","article-title":"Assessment of the patient, health system, and population effects of Xpert MTB\/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach","volume":"2","author":"I Langley","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e0124525","DOI":"10.1371\/journal.pone.0124525","article-title":"Costs and Consequences of Using Interferon-\u03b3 Release Assays for the Diagnosis of Active Tuberculosis in India","volume":"10","author":"KM Little","year":"2014","journal-title":"PloS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e1001347","DOI":"10.1371\/journal.pmed.1001347","article-title":"Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB\/RIF: a dynamic simulation and economic evaluation","volume":"9","author":"NA Menzies","year":"2012","journal-title":"PLoS Med"},{"key":"ref44","first-page":"1196","article-title":"Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country","volume":"12","author":"DH Mueller","year":"2008","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1183\/09031936.04.00009704","article-title":"Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area","volume":"23","author":"I Rajalahti","year":"2004","journal-title":"Eur Respir J"},{"key":"ref46","first-page":"235","article-title":"Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: a theoretical model","volume":"2","author":"BR Roos","year":"1998","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2334-9-216","article-title":"Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis","volume":"9","author":"LC Scherer","year":"2009","journal-title":"BMC Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12879-014-0678-x","article-title":"Smear plus Detect-TB for a sensitive diagnosis of pulmonary tuberculosis: a cost-effectiveness analysis in an incarcerated population","volume":"14","author":"KB Schmid","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/QAD.0000000000000008","article-title":"Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda","volume":"27","author":"M Shah","year":"2013","journal-title":"AIDS Lond Engl"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.5588\/ijtld.15.0158","article-title":"Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India","volume":"19","author":"S-C Suen","year":"2015","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5588\/ijtld.12.0627","article-title":"Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults","volume":"17","author":"D Sun","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e82786","DOI":"10.1371\/journal.pone.0082786","article-title":"Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB\/RIF assay for TB diagnosis: a decision analysis","volume":"8","author":"AH van\u2019t Hoog","year":"2013","journal-title":"PloS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"A Vassall","year":"2011","journal-title":"PLoS Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jinf.2014.12.015","article-title":"Cost-effectiveness analysis of the Xpert MTB\/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area","volume":"70","author":"JHS You","year":"2015","journal-title":"J Infect"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0000000000000712","article-title":"Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis","volume":"70","author":"AA Zwerling","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjophthalmol-2014-306285","article-title":"Cost-effectiveness of alternative strategies for interferon-\u03b3 release assays and tuberculin skin test in tuberculous uveitis","volume":"99","author":"M Ang","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5588\/ijtld.14.0163","article-title":"Sputum induction for tuberculosis diagnosis in an Arctic setting: a cost comparison","volume":"18","author":"J Sugarman","year":"2014","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19340","article-title":"Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis","volume":"19","author":"F Drobniewski","year":"2015","journal-title":"Health Technol Assess Winch Engl"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5588\/ijtld.13.0776","article-title":"Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis","volume":"18","author":"DW Dowdy","year":"2014","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref60","article-title":"The prospective evaluation of the TB strain typing service in England: a mixed methods study","author":"J Mears","year":"2015","journal-title":"Thorax"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/QAD.0b013e3283522d47","article-title":"The cost-effectiveness of routine tuberculosis screening with Xpert MTB\/RIF prior to initiation of antiretroviral therapy: a model-based analysis","volume":"26","author":"JR Andrews","year":"2012","journal-title":"AIDS Lond Engl"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.201004-0620OC","article-title":"Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana","volume":"183","author":"T Samandari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2458-6-157","article-title":"Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants","volume":"6","author":"TC Porco","year":"2006","journal-title":"BMC Public Health"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e1001348","DOI":"10.1371\/journal.pmed.1001348","article-title":"Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis","volume":"9","author":"DE Winetsky","year":"2012","journal-title":"PLoS Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ije\/28.3.563","article-title":"Cost-effectiveness of screening compared to case-finding approaches to tuberculosis in long-term care facilities for the elderly","volume":"28","author":"R Marchand","year":"1999","journal-title":"Int J Epidemiol"},{"key":"ref66","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02565","article-title":"A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis","volume":"3","author":"DW Dowdy","year":"2014","journal-title":"eLife"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10729-012-9201-3","article-title":"Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions","volume":"15","author":"I Langley","year":"2012","journal-title":"Health Care Manag Sci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1017\/S0031182014000985","article-title":"Operational modelling to guide implementation and scale-up of diagnostic tests within the health system: exploring opportunities for parasitic disease diagnostics based on example application for tuberculosis","volume":"141","author":"I Langley","year":"2014","journal-title":"Parasitology"},{"key":"ref69","first-page":"1099","article-title":"Economic analysis of tuberculosis diagnostic tests in disease control: how can it be modelled and what additional information is needed?","volume":"5","author":"D Walker","year":"2001","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"MA de Perio","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/ajrccm\/137.1.215","article-title":"Isoniazid for the tuberculin reactor: take it or leave it","volume":"137","author":"J Tsevat","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values","volume":"36","author":"MR Gold","year":"1998","journal-title":"Med Care"},{"issue":"Suppl 1","key":"ref73","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/hec.3303","article-title":"Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review","volume":"25","author":"TL Drake","year":"2016","journal-title":"Health Econ"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hec.1485","article-title":"Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic","volume":"19","author":"AK Lugn\u00e9r","year":"2010","journal-title":"Health Econ"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0272989X12454578","article-title":"Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5","volume":"32","author":"R Pitman","year":"2012","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2471\/BLT.11.101436","article-title":"The impact of new tuberculosis diagnostics on transmission: why context matters","volume":"90","author":"H-H Lin","year":"2012","journal-title":"Bull World Health Organ"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","article-title":"The transmission of Mycobacterium tuberculosis in high burden settings","volume":"16","author":"TA Yates","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref78","article-title":"Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models","author":"RMGJ Houben","year":"2016","journal-title":"Lancet Glob Health"},{"key":"ref79","unstructured":"Stop TB Partnership. The Global Plan to End TB 2016\u20132020, The Paradigm Shift. In: The Global Plan to End TB 2016\u20132020 [Internet]. 2015 [cited 2 Feb 2016]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stoptb.org\/global\/plan\/plan2\/\" xlink:type=\"simple\">http:\/\/www.stoptb.org\/global\/plan\/plan2\/<\/ext-link>"},{"year":"2015","key":"ref80","article-title":"Indonesia Tuberculosis Prevalence Survey 2013\u20132014"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2214-109X(17)30205-X","article-title":"Cost-effectiveness of Xpert MTB\/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation","volume":"5","author":"A Vassall","year":"2017","journal-title":"Lancet Glob Health"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1473-3099(14)71026-6","article-title":"Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis","volume":"15","author":"NA Menzies","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(13)70360-8","article-title":"Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?","volume":"14","author":"G Theron","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/XEB.0000000000000063","article-title":"Conducting systematic reviews of economic evaluations","volume":"13","author":"J.S. Gomersall","year":"2015","journal-title":"Int. J. Evid. Based Healthc"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1472-6963-13-371","article-title":"Methods of international health technology assessment agencies for economic evaluations\u2014a comparative analysis","volume":"13","author":"T. Mathes","year":"2013","journal-title":"BMC Health Serv. Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/2046-4053-2-83","article-title":"Campbell and Cochrane Economics Methods Group. Issues in the incorporation of economic perspectives and evidence into Cochrane reviews","volume":"2","author":"I. Shemilt","year":"2013","journal-title":"Syst. Rev"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40273-015-0327-2","article-title":"AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users","volume":"34","author":"P Vemer","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40273-013-0106-x","article-title":"The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance","volume":"32","author":"GWJ Frederix","year":"2014","journal-title":"PharmacoEconomics"},{"article-title":"Bill and Melinda Gates Foundation: Methods for Economic Evaluation Project","year":"2014","author":"T Wilkinson","key":"ref89"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:05:48Z","timestamp":1720285548000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193293"}},"subtitle":[],"editor":[{"given":"Jan-Willem","family":"Alffenaar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":89,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193293","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,5,9]]}}}